Swiss drugmaker Novartis to pay up to $1.5 ‌billion for U.K.-based biotechnology firm Myricx Bio in a deal expected ​to close in the second ​half of 2026

https://www.reuters.com/legal/litigation/novartis-acquire-uk-based-myricx-bio-up-15-billion-2026-07-06/